Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 63

1.

Assessment of the function and intergenus-compatibility of Ebola and Lloviu virus proteins.

Kämper L, Zierke L, Schmidt ML, Müller A, Wendt L, Brandt J, Hartmann E, Braun S, Holzerland J, Groseth A, Hoenen T.

J Gen Virol. 2019 May;100(5):760-772. doi: 10.1099/jgv.0.001261. Epub 2019 Apr 24.

PMID:
31017565
2.

Calu-3 cells are largely resistant to entry driven by filovirus glycoproteins and the entry defect can be rescued by directed expression of DC-SIGN or cathepsin L.

González-Hernández M, Müller A, Hoenen T, Hoffmann M, Pöhlmann S.

Virology. 2019 Apr 3;532:22-29. doi: 10.1016/j.virol.2019.03.020. [Epub ahead of print]

PMID:
30999160
3.

Assessing cross-reactivity of Junín virus-directed neutralizing antibodies.

Leske A, Waßmann I, Schnepel K, Shifflett K, Holzerland J, Bostedt L, Bohn P, Mettenleiter TC, Briggiler AM, Brignone J, Enria D, Cordo SM, Hoenen T, Groseth A.

Antiviral Res. 2019 Mar;163:106-116. doi: 10.1016/j.antiviral.2019.01.006. Epub 2019 Jan 19.

PMID:
30668977
4.

Tetherin Inhibits Nipah Virus but Not Ebola Virus Replication in Fruit Bat Cells.

Hoffmann M, Nehlmeier I, Brinkmann C, Krähling V, Behner L, Moldenhauer AS, Krüger N, Nehls J, Schindler M, Hoenen T, Maisner A, Becker S, Pöhlmann S.

J Virol. 2019 Jan 17;93(3). pii: e01821-18. doi: 10.1128/JVI.01821-18. Print 2019 Feb 1.

PMID:
30429347
5.

High-throughput drug screening using the Ebola virus transcription- and replication-competent virus-like particle system.

Lee N, Shum D, König A, Kim H, Heo J, Min S, Lee J, Ko Y, Choi I, Lee H, Radu C, Hoenen T, Min JY, Windisch MP.

Antiviral Res. 2018 Oct;158:226-237. doi: 10.1016/j.antiviral.2018.08.013. Epub 2018 Aug 24.

6.

A genome-wide siRNA screen identifies a druggable host pathway essential for the Ebola virus life cycle.

Martin S, Chiramel AI, Schmidt ML, Chen YC, Whitt N, Watt A, Dunham EC, Shifflett K, Traeger S, Leske A, Buehler E, Martellaro C, Brandt J, Wendt L, Müller A, Peitsch S, Best SM, Stech J, Finke S, Römer-Oberdörfer A, Groseth A, Feldmann H, Hoenen T.

Genome Med. 2018 Aug 7;10(1):58. doi: 10.1186/s13073-018-0570-1.

7.

Generation and Optimization of a Green Fluorescent Protein-Expressing Transcription and Replication-Competent Virus-Like Particle System for Ebola Virus.

Schmidt ML, Tews BA, Groseth A, Hoenen T.

J Infect Dis. 2018 Nov 22;218(suppl_5):S360-S364. doi: 10.1093/infdis/jiy405.

PMID:
30053054
8.

Lifecycle modelling systems support inosine monophosphate dehydrogenase (IMPDH) as a pro-viral factor and antiviral target for New World arenaviruses.

Dunham EC, Leske A, Shifflett K, Watt A, Feldmann H, Hoenen T, Groseth A.

Antiviral Res. 2018 Sep;157:140-150. doi: 10.1016/j.antiviral.2018.07.009. Epub 2018 Jul 19.

PMID:
30031760
9.

Serological Evidence for the Circulation of Ebolaviruses in Pigs From Sierra Leone.

Fischer K, Jabaty J, Suluku R, Strecker T, Groseth A, Fehling SK, Balkema-Buschmann A, Koroma B, Schmidt KM, Atherstone C, Weingartl HM, Mettenleiter TC, Groschup MH, Hoenen T, Diederich S.

J Infect Dis. 2018 Nov 22;218(suppl_5):S305-S311. doi: 10.1093/infdis/jiy330.

PMID:
29982580
10.

Analysis of a Putative Late Domain Using an Ebola Virus Transcription and Replication-Competent Virus-Like Particle System.

Wendt L, Kämper L, Schmidt ML, Mettenleiter TC, Hoenen T.

J Infect Dis. 2018 Nov 22;218(suppl_5):S355-S359. doi: 10.1093/infdis/jiy247.

PMID:
29931371
11.

Characterization of the catalytic center of the Ebola virus L polymerase.

Schmidt ML, Hoenen T.

PLoS Negl Trop Dis. 2017 Oct 9;11(10):e0005996. doi: 10.1371/journal.pntd.0005996. eCollection 2017 Oct.

12.

Minigenome Systems for Filoviruses.

Hoenen T.

Methods Mol Biol. 2018;1604:237-245. doi: 10.1007/978-1-4939-6981-4_18.

PMID:
28986839
13.

Reverse Genetics of Filoviruses.

Hoenen T, Brandt J, Caì Y, Kuhn JH, Finch C.

Curr Top Microbiol Immunol. 2017;411:421-445. doi: 10.1007/82_2017_55.

PMID:
28918537
14.

Ebola virus VP24 interacts with NP to facilitate nucleocapsid assembly and genome packaging.

Banadyga L, Hoenen T, Ambroggio X, Dunham E, Groseth A, Ebihara H.

Sci Rep. 2017 Aug 9;7(1):7698. doi: 10.1038/s41598-017-08167-8.

15.

Enhanced light microscopy visualization of virus particles from Zika virus to filamentous ebolaviruses.

Daaboul GG, Freedman DS, Scherr SM, Carter E, Rosca A, Bernstein D, Mire CE, Agans KN, Hoenen T, Geisbert TW, Ünlü MS, Connor JH.

PLoS One. 2017 Jun 26;12(6):e0179728. doi: 10.1371/journal.pone.0179728. eCollection 2017.

16.

Luciferase-Expressing Ebolaviruses as Tools for Screening of Antivirals.

Hoenen T.

Methods Mol Biol. 2017;1628:189-194. doi: 10.1007/978-1-4939-7116-9_14.

PMID:
28573620
17.

Modeling the Ebolavirus Life Cycle with Transcription and Replication-Competent Viruslike Particle Assays.

Biedenkopf N, Hoenen T.

Methods Mol Biol. 2017;1628:119-131. doi: 10.1007/978-1-4939-7116-9_9.

PMID:
28573615
18.
19.

Reverse Genetics Systems for Filoviruses.

Hoenen T, Feldmann H.

Methods Mol Biol. 2017;1602:159-170. doi: 10.1007/978-1-4939-6964-7_11.

PMID:
28508220
20.

Evolution and Antiviral Specificities of Interferon-Induced Mx Proteins of Bats against Ebola, Influenza, and Other RNA Viruses.

Fuchs J, Hölzer M, Schilling M, Patzina C, Schoen A, Hoenen T, Zimmer G, Marz M, Weber F, Müller MA, Kochs G.

J Virol. 2017 Jul 12;91(15). pii: e00361-17. doi: 10.1128/JVI.00361-17. Print 2017 Aug 1.

Supplemental Content

Loading ...
Support Center